Swiss 3T3 cells were continuously passaged at subconfluence and used to monitor the capacity of compounds to block stimulus-mediated activation of Cdc42 or Rac1 in vivo. Vero E6 cells are responsive to calpeptin-mediated stimulation of RhoA and thus were used as a second cell line for assessing compound effects on RhoA activity. Commercial GLISA kits customized to capture activated Cdc42, Rac1, or RhoA from cell lysates were used per manufacturer's instructions (Cytoskeleton). Cells were serum-starved by sequentially removing serum over a 3-day period and treated with either 0.1% DMSO or 1 or 10 μm compound for 60 min. Subsequently, samples were treated with 100 ng/ml EGF for 2 min to activate Cdc42 or Rac1 or with 1 μg/ml calpeptin for 30 min to activate RhoA. DMSO-treated cells were left either unstimulated to determine base-line GTPase activation or stimulated without drug treatment to determine maximal GTPase activation. Cell lysates were frozen, and active Cdc42 and Rac1 were quantified based on a p21-activated protein kinase binding assay (27 (link)), whereas active RhoA was quantified based on a rhotekin binding assay (28 (link)). All assays were performed in 96-well microtiter plates. Purified GTP-loaded Cdc42, Rac1, or RhoA control proteins were included in each assay to quantify active GTPases in the lysates.
RhoA activation was independently confirmed by monitoring actin stress fiber formation following calpeptin stimulation (1 μg/ml) for 30 min. Actin filaments in control and stimulated cells were detected following paraformaldehyde (4%) fixation and Triton X-100 (0.5%) permeabilization using Alexa Fluor® 488 phalloidin (1 unit, or ∼0.17 μm ) (Life Technologies).
RhoA activation was independently confirmed by monitoring actin stress fiber formation following calpeptin stimulation (1 μg/ml) for 30 min. Actin filaments in control and stimulated cells were detected following paraformaldehyde (4%) fixation and Triton X-100 (0.5%) permeabilization using Alexa Fluor® 488 phalloidin (1 unit, or ∼0.17 μ